was significantly higher than non-pregnant, normal 1st trimester pregnant, and PET women. 51
Conversely, PET sera showed highest levels of the catabolites 3-epi-25(OH)D3 and 24,25-52 dihydroxyvitamin D3 (24,25(OH) 2 D3). Serum albumin was significantly lower in normal 3 rd 53 trimester pregnant women and PET relative to normal 1st trimester pregnant women, but there 54 was no change in free/bioavailable 25(OH)D3. In PET placental tissue, 25(OH)D3 and 3-epi-55 25(OH)D3 were lower than normal 3 rd trimester tissue, whilst placental 24,25(OH) 2 D3 was 56 highest in PET. Tissue 1,25(OH) 2 D3 was detectable in 1 st trimester decidua, which also showed 57
Introduction 1
Human pregnancy is associated with important changes in vitamin D physiology. Maternal 2 circulating concentrations of the active form of vitamin D, 1,25-dihydroxyvitamin D3 3
(1,25(OH) 2 D3), increase significantly during early gestation [1] . This appears to be due to 4 increased renal activity of the enzyme 25-hydroxyvitamin D-1α-hydroxylase (1α-hydroxylase), 5 which converts inactive 25-hydroxyvitamin D (25(OH)D3) to 1,25(OH) 2 D3 [2]. 1α-hydroxylase 6 expression and activity has also been described in human decidua and fetal trophoblast [3] [4] [5] . 7
Placental 1α-hydroxylase does not appear to make a major contribution to the elevated 8 maternal 1,25(OH) 2 D3 associated with pregnancy [2] . Instead co-expression of the nuclear 9 vitamin D receptor (VDR) in maternal and fetal placental tissues suggests a more localised role 10 for 1,25(OH) 2 D3. Albeit less well understood, recent studies suggest this extends far beyond the 11 known classical calciotropic effects of vitamin D, and includes key roles in normal decidual 12 immune function and placental implantation [6-9] 13 14 Vitamin D-insufficiency is prevalent in pregnant women [10, 11] . Maternal 25(OH)D is the 15 principal determinant of neonatal circulating 25(OH)D3, thus infants of vitamin D-deficient 16 mothers are also at risk of vitamin D-deficiency [12] . Maternal 25(OH)D3-deficiency has also 17 been linked to adverse pregnancy outcomes associated with malplacentation, including 18 preeclampsia (PET), small-for-gestational age and preterm birth [13] [14] [15] [16] [17] Importantly, no significant difference in maternal age or BMI was measured. As anticipated, in 51 the PET group mean arterial blood pressure was significantly raised (p<0.0001) and fetal 
Sample preparation for LC-MS/MS Analysis 73
Placental biopsies (approximately 1g weight) were defrosted on ice and homogenised in 700µl 74 ice-cold PBS using a gentle MACS tissue dissociator (Miltenyi Biotec, Woking, UK,) with M 75 tubes using pre-set programs developed for total RNA or mRNA isolation from fresh or frozen 76 samples. Homogenates were centrifuged at 10,000g for 5 minutes and the clear homogenate 
Analysis of DBP and albumin and estimation of free vitamin D metabolites 94
Human vitamin D binding protein (DBP) (R&D Biosystems, Abingdon, UK), and human albumin 95 p<0.0001) groups (Figure 1B) . Consistent with previous studies [28], NP3 levels of 120 1,25(OH) 2 D3 were more than two-fold higher than NP1 (p<0.0001), and significantly lower 121 concentrations of 1,25(OH) 2 D3 (p<0.01) were observed in the PET cohort compared to NP3 122 ( Figure 1B) . Linear regression analysis confirmed gestational age was not a significant 123 determinant of any serum vitamin D metabolite (data not shown). 124 125 Serum concentrations of 24,25(OH) 2 D3 in non-pregnant women (3.3, 1.6-4.7 nmol/L) were 126 higher than NP1 (1.8, 0.8-3.7 nmol/L), but lower than NP3 (7.6, 5.6-10.0 nmol/L, p<0.05) and 127 PET (10.9, 7.3-22.5 nmol/L, p<0.001) ( Figure 1C) . Both NP3 and PET samples showed 128 significantly higher 24,25(OH) 2 D3 concentrations than NP1 (both p<0.0001). Concentrations of
3-epi-25(OH)D3 were lowest in non-pregnant women (5.1, 3.9-6.4 nmol/L). Both NP1 (7.6, 6.0-130 9.2 nmol/L) and NP3 (7.5, 5.9-8.6 nmol/L) had higher levels of 3-epi-25(OH)D3 but this was not 131 significant. Highest 3-epi-25(OH)D3 levels were observed with PET (8.8, 5.9-11.8 nmol/L), with 132 significant differences compared to non-pregnant (p<0.001), NP1 (p<0.05) and NP3 groups 133 (p<0.05) (Figure 1D) . In non-pregnant women serum 25(OH)D3 was strongly correlated with 134 1,25(OH) 2 D3 (p=0.013), 24,25(OH) 2 D3 (p<0.0001) and 3-epi-25(OH)D3 (p=0.012), but similar 135 correlations were not consistently observed in pregnancy (Supplemental Figure 1) . 136 137
Serum DBP, albumin and free/bioavailable 25(OH)D3 138
Data in Figure 2A Figure 2A) . However, the suppression of serum albumin with pregnancy 148 significantly decreased the ratio of 'bioavailable' 25(OH)D3 (25(OH)D3 bound to albumin but not 149 DBP) to 'total' serum 25(OH)D3 across normal pregnancy and PET (Supplemental Figure 2B) . 150
In a similar fashion, elevation of DBP levels in pregnant women resulted in decrease ratios of 151 'free' 25(OH)D3 to total 25(OH)D3, with this effect being more pronounced in PET pregnancies 152 (Supplemental Figure 2C) . interesting that neither maternal nor placental 25(OH)D3 showed any correlation with decidual 219 25(OH)D3, despite the proximity of these tissues (Supplemental Figure 2) , suggesting that the 220 the decidua has an autonomously regulated vitamin D system. Figure 3) . It has been recognised for many years that serum 237 albumin decreases with pregnancy, due to increased maternal blood volume [38] . This may be 238 exacerbated in PET, although the extent to which this occurs varies with disease severity [38] . 239
Previous studies using 1 st trimester serum did not demonstrate any significant variation in DBP 240 or 25(OH)D3 between pregnancies that went on to normal term or PET delivery [39] . 241
For both NP1 and NP3, serum DBP correlated with placental DBP, but this was not observed in 242
PET placentas, or NP1 decidua (Supplemental Figure 4A) . PET may therefore involve 243 The validity of the monoclonal antibody to DBP used in the R&D assay employed in the current 260 study has been subject to recent debate, specifically reported differential immunoreactivity 261 against epitopes on major DBP isoforms [42, 43] . This potential limitation of the DBP assay is 262 specifically relevant to black populations, and it is important to recognise that the cohort in the 263 current study was predominantly white. Nevertheless, future studies will benefit from direct 264 measurement method for 'free' 25(OH)D3 and using newly established assays [44] . 265
266
The over-arching conclusions from this study are: 1) that PET is characterised by changes in 267 multiple vitamin D metabolic pathways, emphasising the limited information to be gained from 268 
